# Predictives Factors of Cardiac Resynchronization Therapy: a Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy and Heart Failure Biomarkers

> **NCT02018029** · — · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 300 (estimated)

## Conditions studied

- Heart Failure
- Reduced Ejection Fraction

## Interventions

- **OTHER:** cardiac resynchronisation therapy

## Key facts

- **NCT ID:** NCT02018029
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018029, "Predictives Factors of Cardiac Resynchronization Therapy: a Multimodal Analysis Using 2D Speckle Tracking Echocardiography Coupled With MIBG Myocardial Scintigraphy and Heart Failure Biomarkers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02018029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*